Cytogel Pharma: Funding, Investors & Team (Sep 2026)
Cytogel Pharma is a biopharmaceutical improvement organization that seeks after essential open doors for drug item advancement. The organization centers around getting promising beginning phase programs that offer critical potential both as stage advancements and high-esteem item up-and-comers. Achievement characterized venture of corporate assets allows the organization to improve item an incentive for collaborating or permitting while at the same time holding ideal value an incentive for its financial backers. Cytogel is adventure upheld by Centripetal Capital Partners. Cytogel Pharma was established in 2002 and is situated in Darien, Connecticut.
Cytogel Pharma has raised $50k across 1 funding round on record, the most recent a Debt Financing of $50k announced in Jul 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cytogel Pharma Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Cytogel Pharma Funding Rounds
Cytogel Pharma Founders and Leadership Team
No contact details are on record for this team yet.
Cytogel Pharma Funding Compared to Other Biotechnology Startups
Cytogel Pharma's latest round of $50k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cytogel Pharma in Biotechnology and Darien
Companies Similar to Cytogel Pharma
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Cytogel Pharma Funding FAQs
What does Cytogel Pharma do?
Cytogel Pharma is a biopharmaceutical improvement organization that seeks after essential open doors for drug item advancement. The organization centers around getting promising beginning phase programs that offer critical potential both as stage advancements and high-esteem item up-and-comers. Achievement characterized venture of corporate assets allows the organization to improve item an incentive for collaborating or permitting while at the same time holding ideal value an incentive for its financial backers. Cytogel is adventure upheld by Centripetal Capital Partners. Cytogel Pharma was established in 2002 and is situated in Darien, Connecticut.
How much funding has Cytogel Pharma raised?
Cytogel Pharma has raised $50k across 1 round on record. The most recent is a Debt Financing of $50k announced in Jul 2022.
When did Cytogel Pharma last raise funding?
Cytogel Pharma's most recent funding round on record is a Debt Financing of $50k, announced in Jul 2022.
Who is the CEO of Cytogel Pharma?
C Dean Maglaris is listed as CEO at Cytogel Pharma.
Where is Cytogel Pharma headquartered?
Cytogel Pharma is based in Darien, Connecticut, United States.
How many employees does Cytogel Pharma have?
Cytogel Pharma is in the 1-10 employee band.
How does Cytogel Pharma's funding compare to other Biotechnology startups?
Cytogel Pharma's latest round of $50k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Cytogel Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cytogel Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.